United States · FDA National Drug Code directory
Thyropar
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44911-0535_1387214b-6ef9-4562-aa90-3a7c31bd7c61
- Product NDC
- 44911-0535
- Form
- LIQUID
- Composition / generic term
- Fucus Vesiculosus, Spongia Tosta, Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Bromium, Calcarea Carbonica, Iodium, Lachesis Mutus, Pulsatilla (Pratensis)
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20200302 / 20261207
Source-listed ingredients
- FUCUS VESICULOSUS — 3 [hp_X]/mL
- SPONGIA OFFICINALIS SKELETON, ROASTED — 3 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND — 6 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND — 6 [hp_X]/mL
- SUS SCROFA THYROID — 6 [hp_X]/mL
- BROMINE — 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE — 12 [hp_X]/mL
- IODINE — 12 [hp_X]/mL
- LACHESIS MUTA VENOM — 12 [hp_X]/mL
- ANEMONE PRATENSIS — 12 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (44911-0535-1) · 44911-0535-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →